Medication info
Famciclovir Tablets (Famciclovir)

Famciclovir Tablets (Famciclovir)

Prescription medicationTabletOral
Ingredient · strength
Famciclovir›250mg / 1 tablet
Manufacturer / importer
Nexpam Korea Co., Ltd.
Appearance
White to light yellow oblong film-coated tablets
Packaging
21 tablets/bottle
Approval status
Active

MFDS item code 200503301 · Notified 2005.08.10 · Insurance code 662501780

Summary

Main use
Treatment and suppression of shingles, genital herpes, and herpes simplex (cold sores)
Who takes it
Adults
Adult dose
1. Treatment of herpes zoster Adults: Administer famciclovir 250 mg per dose orally 3 times daily for 7 days. It is preferable to start treatment as soon as symptoms appear after infection. 2. Treatment of initial genital herpes infection Adults: Administer 250 mg of this medicine per dose orally 3 times daily for 5 days. It is preferable to start treatment as soon as symptoms appear after infection. 3. Treatment of acute recurrent genital herpes infection Adults: Administer 125 mg of this medicine per dose orally twice daily for 5 days. It is preferable to start treatment during the prodromal period or as soon as symptoms appear after infection. 4. Suppression of recurrent genital herpes Adults: Administer 250 mg of this medicine per dose orally twice daily. Periodically discontinue treatment every 6~12 months to assess whether the natural course of the disease has changed. 5. Patients with renal impairment: Since the clearance of this medicine is reduced in patients with renal impairment, dose adjustment should be undertaken with caution. The dosage and administration for these patients are as follows. 1) Treatment of herpes zoster and initial genital herpes infection: Creatinine clearance (mL/min/1.73㎡) Dose 30~59 250 mg per dose twice daily 10~29 250 mg per dose once daily 2) Treatment of acute recurrent genital herpes infection: Creatinine clearance (mL/min/1.73㎡) Dose 30~59 125 mg per dose twice daily 10~29 125 mg per dose once daily 3) Suppression of recurrent genital herpes infection: Creatinine clearance (mL/min/1.73㎡) Dose 30~59 250 mg per dose twice daily 10~29 125 mg per dose twice daily 4) If only serum creatinine is known, creatinine clearance can be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 5) Patients with renal impairment undergoing hemodialysis For patients on hemodialysis, it is preferable to administer this medicine every 48 hours, taking the dialysis interval into account. Since 4 hours of hemodialysis reduces the plasma concentration of this medicine by approximately 75%, administer this medicine immediately after dialysis. The recommended dose is 250mg for patients with herpes zoster and 125mg for patients with genital herpes. 6. Patients with hepatic impairment: No dose adjustment is necessary in patients with chronic compensated liver disease. There is insufficient treatment experience in patients with overt chronic decompensated liver disease; therefore, no clear recommended dose has been established.

Ingredients

Manufacturer
Nexpam Korea Co., Ltd.

Efficacy & effects

Treatment and suppression of shingles, genital herpes, and herpes simplex (cold sores)

  • Shingles virus infection
  • genital herpes infection
  • recurrent genital herpes
  • herpes simplex virus infection
  • cold sores
View approved original text

This medication is used to treat infections caused by the varicella-zoster virus and genital herpes infections, especially to inhibit the recurrence of recurrent genital herpes. It is also used for the treatment and suppression of infections caused by the varicella-zoster and herpes simplex viruses in patients with weakened immune function. Cream formulations are effective for herpes simplex virus infections, including cold sores. It helps effectively treat and manage viral herpes infections in various forms and dosages.

How to take

Adult dose

1. Treatment of herpes zoster Adults: Administer famciclovir 250 mg per dose orally 3 times daily for 7 days. It is preferable to start treatment as soon as symptoms appear after infection. 2. Treatment of initial genital herpes infection Adults: Administer 250 mg of this medicine per dose orally 3 times daily for 5 days. It is preferable to start treatment as soon as symptoms appear after infection. 3. Treatment of acute recurrent genital herpes infection Adults: Administer 125 mg of this medicine per dose orally twice daily for 5 days. It is preferable to start treatment during the prodromal period or as soon as symptoms appear after infection. 4. Suppression of recurrent genital herpes Adults: Administer 250 mg of this medicine per dose orally twice daily. Periodically discontinue treatment every 6~12 months to assess whether the natural course of the disease has changed. 5. Patients with renal impairment: Since the clearance of this medicine is reduced in patients with renal impairment, dose adjustment should be undertaken with caution. The dosage and administration for these patients are as follows. 1) Treatment of herpes zoster and initial genital herpes infection: Creatinine clearance (mL/min/1.73㎡) Dose 30~59 250 mg per dose twice daily 10~29 250 mg per dose once daily 2) Treatment of acute recurrent genital herpes infection: Creatinine clearance (mL/min/1.73㎡) Dose 30~59 125 mg per dose twice daily 10~29 125 mg per dose once daily 3) Suppression of recurrent genital herpes infection: Creatinine clearance (mL/min/1.73㎡) Dose 30~59 250 mg per dose twice daily 10~29 125 mg per dose twice daily 4) If only serum creatinine is known, creatinine clearance can be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 5) Patients with renal impairment undergoing hemodialysis For patients on hemodialysis, it is preferable to administer this medicine every 48 hours, taking the dialysis interval into account. Since 4 hours of hemodialysis reduces the plasma concentration of this medicine by approximately 75%, administer this medicine immediately after dialysis. The recommended dose is 250mg for patients with herpes zoster and 125mg for patients with genital herpes. 6. Patients with hepatic impairment: No dose adjustment is necessary in patients with chronic compensated liver disease. There is insufficient treatment experience in patients with overt chronic decompensated liver disease; therefore, no clear recommended dose has been established.

Precautions

This medication should not be used by patients who have had an allergic reaction to this drug or its main ingredient, penciclovir. Additionally, it contains lactose, so individuals with lactose intolerance or certain genetic lactose metabolism disorders should not take it. Patients with impaired kidney function should use this medication with caution, and dosage adjustments may be needed. Taking this medication may result in side effects such as headache, nausea, dizziness, drowsiness, skin rash, and liver function abnormalities; if symptoms are severe, consult a physician. This drug does not completely cure genital herpes, so it is essential to avoid sexual contact when symptoms are present and to practice safe sex. If you experience dizziness or drowsiness while taking this medication, avoid driving or operating machinery. Generally, elderly patients do not need dosage adjustments, but those with reduced kidney function should have their dosage adjusted. In case of overdose, hemodialysis may be beneficial, so visit a medical institution immediately. Store this medication in a dry place below 30 degrees Celsius and out of reach of children, and do not transfer it to another container.

Side effects

  • Headache
  • nausea
  • thrombocytopenia
  • leukopenia
  • neutropenia
  • dizziness
  • confusion
  • drowsiness
  • hallucinations
  • palpitations
Show 22 more
  • vomiting
  • abdominal pain
  • diarrhea
  • abnormal liver function tests
  • jaundice
  • skin rash
  • itching
  • urticaria
  • angioedema
  • acute kidney failure
  • upper abdominal pain
  • constipation
  • liver function abnormalities
  • abdominal distension
  • indigestion
  • facial swelling
  • fatigue
  • pain
  • leukopenia
  • insomnia
  • shortened menstrual period
  • difficulty urinating

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is also recommended to keep it in a cool, dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

White to light yellow oblong film-coated tablets

Package unit

21 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.